Academician profile · PROFESÖR
YEŞİM AYDINOK
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Çocuk Hematolojisi ve Onkolojisi (Çocuk Sağlığı ve Hastalıkları)
- TIP FAKÜLTESİ
- DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
Scopus (SJR)
Q1
97
Q2
37
Q3
22
Q4
5
WoS (JCR)
Q1
72
Q2
27
Q3
29
Q4
36
TR Index
13
articles
Articles
- 2026 Avatrombopag for treating children and adolescents with immune thrombocytopenia: a plain language summary
- 2025 Luspatercept versus mitapivat for non‐transfusion‐dependent β‐thalassemia: Dare to compare?
- 2025 Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study
- 2025 Avatrombopag for treating children and adolescents with immune thrombocytopenia: a plain language summary
- 2025 Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial
- 2025 Luspatercept versus mitapivat for non-transfusion-dependent β-thalassemia: Dare to compare?
- 2024 Identification of the molecular etiology in rare congenital hemolytic anemias using next‐generation sequencing with exome‐based copy number variant analysis
- 2024 Systematic literature review of the indirect costs and humanistic burden of β-thalassemia
- 2024 Evaluation of the Effectiveness of Convalescent Plasma Therapy in Severe and Critical COVID-19
- 2024 Identification of the molecular etiology in rare congenital hemolytic anemias using next-generation sequencing with exome-based copy number variant analysis
- 2023 Compliance and clinical benefit of deferasirox granule and dispersible tablet formulation in pediatric patients with transfusional iron overload: in a randomized, open-label, multicenter, phase II study
- 2023 Invasive Fungal Infections in Children With Acute Myeloid Leukemia: A Single-center Experience Over 19 Years
- 2023 Highlights on the Luspatercept Treatment in Thalassemia
- 2023 Combination chelation therapy
- 2023 Current childhood chronic myeloid leukemia management under tyrosine kinase inhibitor treatment
- 2022 Modern management of iron overload in thalassemia major patients guided by MRI techniques: real-world data from a long-term cohort study.
- 2022 Modern management of iron overload in thalassemia major patients guided by MRI techniques: real-world data from a long-term cohort study
- 2022 An open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results.
- 2022 Current childhood chronic myeloid leukemia management under tyrosine kinase inhibitor treatment.
- 2022 Thalassaemia